Regeneron Pharmaceuticals, Inc. earnings per share and revenue

REGN earnings per share for the last quarter are 11.56 USD whereas the estimation was 10.62 USD which accounts for 8.87% surprise. Company revenue for the same period amounts to 3.55 B USD despite the estimated figure of 3.38 B USD. Estimated earnings per share for the next quarter are 11.84 USD, and revenue is expected to reach 3.66 B USD. Also watch annual changes over time to get a bigger picture of REGN earnings per share and revenue dynamics.